全球血液筛检市场规模、份额、成长分析、按产品类型、最终用户划分 - 产业预测，2024-2031 年

Global Blood Screening Market Size, Share, Growth Analysis, By Product Type(Reagents & Kits, Instruments), By End User(Hospitals & Clinics, Blood Banks) - Industry Forecast 2024-2031

出版日期: 2024年04月10日 | 出版商:

SkyQuest | 英文 219 Pages | 商品交期: 3-5个工作天内

价格

简介目录

2022年全球血液筛检市场规模将为27.3亿美元，预测期内（2024-2031年）复合年增长率为8.50%，从2023年的29.6亿美元增长到2031年的29.6亿美元。到美国9000万美元。

用于血液筛检的自动化分子平台在业界领先的公司中越来越受欢迎，并正在推动市场扩张。血液筛检市场的成长是由几个关键因素推动的，例如捐血和捐血数量的增加、对捐血安全意识的提高、感染疾病的迅速增加以及各种政府措施。根据 2021 年 12 月的报导《手术风险》，全球每年进行超过 2.34 亿例大型手术，这进一步加剧了这一激增。此外，在难产期间经常使用输血来解决急性儿童贫血、创伤和先天性母体血液异常等问题。此外，根据世界卫生组织（WHO）2021年6月情况说明书的资料，全球有1.185亿次捐血，其中40%来自高所得国家。值得注意的是，捐血与收入水准的比率在高所得国家为31.5%，在中高收入国家为15.9%，在中低收入国家为6.8%，在低收入国家为5.0% ，差距就凸显出来了。

市场概况
北美洲
- 美国
- 加拿大
欧洲
- 德国
- 西班牙
- 法国
- 英国
- 其他欧洲国家地区
亚太地区
- 中国
- 印度
- 日本
- 韩国
- 其他亚太地区
拉丁美洲
- 巴西
- 其他拉丁美洲地区
中东和非洲 (MEA)
- 海湾合作委员会国家
- 南非
- 其他中东/非洲地区

竞争格局

前5名企业对比
主要企业市场定位（2021年）
主要市场参与者所采取的策略
关键成功策略
近期市集活动
主要企业市场占有率（2021年）

主要企业简介

Abbott Laboratories（USA）
Becton, Dickinson and Company（USA）
Bio-Rad Laboratories, Inc.（USA）
bioMA（C）rieux SA（France）
F. Hoffmann-La Roche Ltd.（Switzerland）
Grifols, SA（Spain）
Hologic, Inc.（USA）
Immucor, Inc.（USA）
Meridian Bioscience, Inc.（USA）
Ortho Clinical Diagnostics（USA）
Quotient Limited（UK）
Siemens Healthineers AG（Germany）
Sysmex Corporation（Japan）
Thermo Fisher Scientific Inc.（USA）
Danaher Corporation（USA）
Grifols Diagnostic Solutions Inc.（USA）
Haemonetics Corporation（USA）
Luminex Corporation（USA）
Natera, Inc.（USA）
Novartis International AG（Switzerland）
PerkinElmer, Inc.（USA）
Promega Corporation（USA）

简介目录

Product Code: SQMIG35J2044

Global Blood Screening Market size was valued at USD 2.73 Billion in 2022 and is poised to grow from USD 2.96 Billion in 2023 to USD 5.69 Billion by 2031, at a CAGR of 8.50% during the forecast period (2024-2031).

Automated molecular platforms for Blood Screening have become increasingly popular among leading industry players, driving market expansion. The growth of the Blood Screening market is fueled by several key factors including the escalating number of blood donations and donors, heightened awareness regarding the safety of donated blood, the surge in infectious diseases, and various governmental initiatives. This surge is further bolstered by the staggering volume of major surgeries conducted worldwide annually, surpassing 234 million according to the December 2021 article "Operative Risk". Additionally, blood transfusions are frequently administered in challenging childbirths to address issues like childhood acute anaemia, trauma, and congenital maternal blood abnormalities. Furthermore, data from the World Health Organization (WHO) Factsheet of June 2021 indicates that 118.5 million blood donations are made globally, with 40% originating from high-income countries, despite these countries only representing 16% of global blood donations. Notably, the proportion of donations relative to income levels highlights disparities, with high-income nations contributing 31.5%, upper-middle-income nations 15.9%, lower-middle-income nations 6.8%, and low-income nations 5.0%.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Blood Screening Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Blood Screening Market Segmental Analysis

Global Blood Screening Market is segmented on the basis of product type, end users and region. By product type, the market is segmented into reagents & kits, instruments, software. By end user, the market is segmented into hospitals & clinics, blood banks, diagnostic centers, and research laboratories. By region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

Drivers of the Global Blood Screening Market

Healthcare professionals and patients are increasingly recognizing the potential dangers linked with blood transfusions, including the transmission of infectious diseases. Consequently, there is a rising need for blood screening products that guarantee the safety of both blood and blood-related products.

Restraints in the Global Blood Screening Market

The scarcity of phlebotomists, laboratory technicians, and other skilled workers in the industry could impede the widespread adoption of blood screening products. Healthcare institutions and blood banks may encounter difficulties in finding qualified personnel to operate the equipment and conduct tests, potentially limiting their ability to implement comprehensive blood screening programs.

Market Trends of the Global Blood Screening Market

The increasing demand for plasma-derived products like immunoglobulins and clotting factors is fueling the need for advanced blood screening tools to guarantee the safety of these products. This upward trajectory is projected to persist as the utilization of plasma-derived products extends into emerging therapeutic domains.

Executive Summary

Market Overview
Wheel of Fortune

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Parent Market Analysis

Market Overview
Market Size
Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges

Key Market Insights

Technology Analysis
Pricing Analysis
Supply Chain Analysis
Value Chain Analysis
Ecosystem of the Market
IP Analysis
Trade Analysis
Startup Analysis
Raw Material Analysis
Innovation Matrix
Pipeline Product Analysis
Macroeconomic Indicators
Top Investment Analysis
Key Success Factor
Degree of Competition

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Regulatory Landscape
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers
Skyquest Special Insights on Future Disruptions
- Political Impact
- Economic Impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact

Global Blood Screening Market by Product Type

Market Overview
Reagents & Kits
Instruments
Software

Global Blood Screening Market by End User

Market Overview
Hospitals & Clinics
Blood Banks
Diagnostic Centers
Research Laboratories

Global Blood Screening Market Size by Region

Market Overview
North America
- USA
- Canada
Europe
- Germany
- Spain
- France
- UK
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2021
Strategies Adopted by Key Market Players
Top Winning Strategies
- By Development
- By Company
- By Year
Recent Activities in the Market
Key Companies Market Share (%), 2021

Key Company Profiles

Abbott Laboratories (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Becton, Dickinson and Company (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bio-Rad Laboratories, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
bioMA(C)rieux SA (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
F. Hoffmann-La Roche Ltd. (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Grifols, S.A. (Spain)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Hologic, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Immucor, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Meridian Bioscience, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Ortho Clinical Diagnostics (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Quotient Limited (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Siemens Healthineers AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sysmex Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Thermo Fisher Scientific Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Danaher Corporation (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Grifols Diagnostic Solutions Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Haemonetics Corporation (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Luminex Corporation (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Natera, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Novartis International AG (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
PerkinElmer, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Promega Corporation (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments